0001209191-21-033399.txt : 20210518 0001209191-21-033399.hdr.sgml : 20210518 20210518113511 ACCESSION NUMBER: 0001209191-21-033399 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210517 FILED AS OF DATE: 20210518 DATE AS OF CHANGE: 20210518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Jason Drew CENTRAL INDEX KEY: 0001821479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 21934866 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 400 ALEXANDER PARK DRIVE CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-17 0 0001668243 UroGen Pharma Ltd. URGN 0001821479 Smith Jason Drew C/O UROGEN PHARMA LTD. 400 ALEXANDER PARK DRIVE PRINCETON NJ 08540 0 1 0 0 General Counsel Common Stock 2021-05-17 4 P 0 2500 15.71 A 2500 D The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.675 and 15.76, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. /s/ Jason D. Smith 2021-05-17